John A. Meyers, PhD

Assistant Professor, Medicine

John Meyers
650 Albany St Evans Biomed Research Ctr


Expertise includes: CLL; Leukemia; Lymphoid malignancies; B cell signaling; T cell development; Autoimmunity; cAMP signaling; Flow cytometry; Big Data anlaytics; and Informatics.

Other Positions

  • Boston Medical Center


  • Boston University School of Medicine, PhD
  • Boston University, MA
  • Bowdoin College, AB


  • Published on 6/13/2016

    Xu C, Wyman AR, Alaamery MA, Argueta SA, Ivey FD, Meyers JA, Lerner A, Burdo TH, Connolly T, Hoffman CS, Chiles TC. Anti-inflammatory effects of novel barbituric acid derivatives in T lymphocytes. Int Immunopharmacol. 2016 Sep; 38:223-32. PMID: 27302770.

    Read at: PubMed
  • Published on 1/1/2015

    Tan Y, Watkins AA, Freeman BB, Meyers JA, Rifkin IR, Lerner A. Inhibition of type 4 cyclic nucleotide phosphodiesterase blocks intracellular TLR signaling in chronic lymphocytic leukemia and normal hematopoietic cells. J Immunol. 2015 Jan 1; 194(1):101-12. PMID: 25416804.

    Read at: PubMed
  • Published on 5/1/2009

    Meyers JA, Su DW, Lerner A. Chronic lymphocytic leukemia and B and T cells differ in their response to cyclic nucleotide phosphodiesterase inhibitors. J Immunol. 2009 May 1; 182(9):5400-11. PMID: 19380787.

    Read at: PubMed
  • Published on 8/15/2007

    Meyers JA, Taverna J, Chaves J, Makkinje A, Lerner A. Phosphodiesterase 4 inhibitors augment levels of glucocorticoid receptor in B cell chronic lymphocytic leukemia but not in normal circulating hematopoietic cells. Clin Cancer Res. 2007 Aug 15; 13(16):4920-7. PMID: 17699872.

    Read at: PubMed
  • Published on 4/19/2007

    Mineva ND, Rothstein TL, Meyers JA, Lerner A, Sonenshein GE. CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis. J Biol Chem. 2007 Jun 15; 282(24):17475-85. PMID: 17446175.

    Read at: PubMed
  • Published on 1/1/2007

    Everett PC, Meyers JA, Makkinje A, Rabbi M, Lerner A. Preclinical assessment of curcumin as a potential therapy for B-CLL. Am J Hematol. 2007 Jan; 82(1):23-30. PMID: 16947318.

    Read at: PubMed
  • Published on 10/18/2006

    Meyers JA, Mangini AJ, Nagai T, Roff CF, Sehy D, van Seventer GA, van Seventer JM. Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-gamma and IL-17 secretion by activated human PBMC. Cytokine. 2006 Sep; 35(5-6):235-46. PMID: 17052915.

    Read at: PubMed

View all profiles